US FDA revises safety advice on albumin administration

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1054, 2005-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

US FDA revises labelling for PPIs

By  

Reactions Weekly, Vol. 1, Iss. 1304, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

US FDA reviewing safety of orlistat

By  

Reactions Weekly, Vol. 1, Iss. 1267, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

US FDA reviews safety of Stalevo

By  

Reactions Weekly, Vol. 1, Iss. 1297, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Safety and efficacy of albumin administration in trauma

By Chalidis Byron   Kanakaris Nikolaos   Giannoudis Peter V  

Expert Opinion on Drug Safety, Vol. 6, Iss. 4, 2007-07 ,pp. : 407-415

Informa Healthcare

Access to resources Recommend Favorite

US FDA reviewing safety of ezetimibe/simvastatin

By  

Reactions Weekly, Vol. 1, Iss. 1217, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite